ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)

Q: What does CUSIP H0036K147 represent in this 13F holders report?

CUSIP H0036K147 is the security identifier for ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share used to aggregate holder disclosures.

Q: How many institutions held ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share in Q2 2023?

55 institutional investors reported ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share for Q2 2023. Use the holders table for investor-level position and value details.

CUSIP: H0036K147

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Shares, par value CHF 0.08 per share
Shares outstanding: 128,459,465
Total 13F shares: 45,357,348
Share change: -1,253,787
Total reported value: $97,515,460
Put/Call ratio: 3700%
Price per share: $2.15
Number of holders: 55
Value change: -$1,939,928
Number of buys: 23
Number of sells: 30

Quarterly Holders Quick Answers

What is CUSIP H0036K147?
CUSIP H0036K147 identifies ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP H0036K147:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Redmile Group, LLC	13F	Company	11%	13,565,249	$26,452,236	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	2.6%	3,366,704	$6,565,073	—	31 Mar 2023	13F
Prosight Management, LP	13F	Company	2.5%	3,257,360	$6,351,852	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	2.4%	3,091,814	$6,029,000	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.8%	2,353,705	$4,589,725	—	31 Mar 2023	13F
Sio Capital Management, LLC	13F	Company	1.7%	2,160,632	$4,213,232	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.4%	1,793,192	$3,497,000	—	31 Mar 2023	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	1.3%	1,675,959	$3,268,120	—	31 Mar 2023	13F
Frazier Life Sciences Management, L.P.	13F	Company	1.3%	1,647,030	$3,211,709	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	1.3%	1,644,808	$3,207,376	—	31 Mar 2023	13F
PERCEPTIVE ADVISORS LLC	13F	Company	1.2%	1,495,805	$2,916,820	—	31 Mar 2023	13F
PICTET ASSET MANAGEMENT SA	13F	Company	1.1%	1,366,689	$2,665,044	—	31 Mar 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1%	1,306,438	$2,548,000	—	31 Mar 2023	13F
Vantage Consulting Group Inc	13F	Company	0.92%	1,186,215	$2,313,119	—	31 Mar 2023	13F
Nantahala Capital Management, LLC	13F	Company	0.65%	840,000	$1,638,000	—	31 Mar 2023	13F
AlphaCentric Advisors LLC	13F	Company	0.59%	760,000	$1,482,000	—	31 Mar 2023	13F
Blue Owl Capital Holdings LP	13F	Company	0.57%	733,568	$1,430,458	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	0.49%	635,547	$1,239,316	—	31 Mar 2023	13F
Affinity Asset Advisors, LLC	13F	Company	0.47%	600,000	$1,170,000	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.34%	437,949	$854,001	—	31 Mar 2023	13F
GCM Grosvenor Holdings, LLC	13F	Company	0.32%	410,888	$801,232	—	31 Mar 2023	13F
BARCLAYS PLC	13F	Company	0.26%	334,272	$651,830	—	31 Mar 2023	13F
XTX Topco Ltd	13F	Company	0.21%	266,259	$519,205	—	31 Mar 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.17%	223,827	$436,463	—	31 Mar 2023	13F
MARSHALL WACE, LLP	13F	Company	0.12%	157,679	$307,475	—	31 Mar 2023	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.11%	146,566	$285,804	—	31 Mar 2023	13F
Woodline Partners LP	13F	Company	0.11%	143,403	$279,636	—	31 Mar 2023	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.1%	125,985	$245,671	—	31 Mar 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.09%	112,906	$220,167	—	31 Mar 2023	13F
Squarepoint Ops LLC	13F	Company	0.08%	104,547	$203,867	—	31 Mar 2023	13F
Indie Asset Partners, LLC	13F	Company	0.07%	93,839	$182,986	—	31 Mar 2023	13F
Qube Research & Technologies Ltd	13F	Company	0.06%	77,166	$150,474	—	31 Mar 2023	13F
TD ASSET MANAGEMENT INC	13F	Company	0.06%	74,690	$145,646	—	31 Mar 2023	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	0.04%	57,066	$111,000	—	31 Mar 2023	13F
Magnetar Financial LLC	13F	Company	0.04%	55,762	$108,736	—	31 Mar 2023	13F
FMR LLC	13F	Company	0.03%	40,444	$78,866	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.02%	26,028	$50,755	—	31 Mar 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.02%	25,584	$49,889	—	31 Mar 2023	13F
Cubist Systematic Strategies, LLC	13F	Company	0.02%	25,046	$48,840	—	31 Mar 2023	13F
Rockefeller Capital Management L.P.	13F	Company	0.02%	24,701	$48,000	—	31 Mar 2023	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.02%	23,648	$46,000	—	31 Mar 2023	13F
MONETA GROUP INVESTMENT ADVISORS LLC	13F	Company	0.02%	19,496	$38,017	—	31 Mar 2023	13F
HRT FINANCIAL LP	13F	Company	0.01%	16,334	$31,000	—	31 Mar 2023	13F
IHT Wealth Management, LLC	13F	Company	0.01%	15,110	$29,466	—	31 Mar 2023	13F
Dynamic Technology Lab Private Ltd	13F	Company	0.01%	14,332	$28,000	—	31 Mar 2023	13F
Values First Advisors, Inc.	13F	Company	0.01%	13,019	$25,388	—	31 Mar 2023	13F
Prospera Financial Services Inc	13F	Company	0.01%	12,623	$24,614	—	31 Mar 2023	13F
UBS Group AG	13F	Company	0.01%	11,302	$22,039	—	31 Mar 2023	13F
Verition Fund Management LLC	13F	Company	0.01%	11,241	$21,920	—	31 Mar 2023	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	0.01%	10,093	$19,000	—	31 Mar 2023	13F

Institutional Holders of ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) as of Q2 2023

As of 30 Jun 2023, ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) was held by 55 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,357,348 shares. The largest 10 holders included Redmile Group, LLC, Prosight Management, LP, Sio Capital Management, LLC, CITADEL ADVISORS LLC, JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, Frazier Life Sciences Management, L.P., MILLENNIUM MANAGEMENT LLC, PICTET ASSET MANAGEMENT SA, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 55 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

-2

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.